These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11284459)

  • 1. Is parenteral methotrexate worth trying?
    Osman A; Mulherin D
    Ann Rheum Dis; 2001 Apr; 60(4):432. PubMed ID: 11284459
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenteral methotrexate for the treatment of rheumatoid arthritis.
    Yazici Y; Bata Y
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramuscular methotrexate in inflammatory rheumatic disease.
    Burbage G; Gupta R; Lim K
    Ann Rheum Dis; 2001 Dec; 60(12):1156. PubMed ID: 11760723
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Thornton C; Ong V; Ward J; Kennedy N; Steuer A
    Rheumatology (Oxford); 2008 Sep; 47(9):1438; author reply 1438. PubMed ID: 18617550
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.
    Rozin A; Schapira D; Balbir-Gurman A; Braun-Moscovici Y; Markovits D; Militianu D; Nahir MA
    Ann Rheum Dis; 2002 Aug; 61(8):756-7. PubMed ID: 12117691
    [No Abstract]   [Full Text] [Related]  

  • 7. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.
    Wegrzyn J; Adeleine P; Miossec P
    Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
    Hameed B; Jones H
    Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
    [No Abstract]   [Full Text] [Related]  

  • 9. Parenteral methotrexate should be given before biological therapy.
    Griffin AJ; Erkeller-Yuksel F
    Rheumatology (Oxford); 2004 May; 43(5):678; author reply 678-9. PubMed ID: 15103040
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance.
    Dhir V; Aggarwal A
    J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 13. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Why we recommend parenteral methotrexate for the treatment of rheumatoid arthritis: a response and overview of the literature].
    Fiehn C;
    Z Rheumatol; 2019 May; 78(4):385-387. PubMed ID: 30941504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 17. Summaries for patients. Adding low-dose prednisone to methotrexate therapy for early rheumatoid arthritis.
    Ann Intern Med; 2012 Mar; 156(5):I18. PubMed ID: 22393145
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot study using the combination of methotrexate and thalidomide in the treatment of rheumatoid arthritis.
    Scoville CD
    Clin Exp Rheumatol; 2001; 19(3):360-1. PubMed ID: 11407104
    [No Abstract]   [Full Text] [Related]  

  • 19. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
    Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
    Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
    [No Abstract]   [Full Text] [Related]  

  • 20. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
    Dervieux T; Zablocki R; Kremer J
    Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.